Pharmacyclics Announces Date of Conference call to discuss Financial Results for Fourth Quarter and Year End 2013

 Pharmacyclics Announces Date of Conference call to discuss Financial Results
                     for Fourth Quarter and Year End 2013

PR Newswire

SUNNYVALE, Calif., Feb. 14, 2014

SUNNYVALE, Calif., Feb. 14, 2014 /PRNewswire/ --Pharmacyclics, Inc. (the
"Company") (Nasdaq: PCYC) today announced that it will hold a conference call
and audio webcast to discuss financial results for its fourth quarter and full
year ended December 31, 2013 after the NASDAQ Market closes on Thursday,
February 20, 2014 at 4:30 p.m. ET.

Conference call and webcast details:

Date: February 20, 2014
Time: 4:30 PM ET
Listen via Internet: http://ir.pharmacyclics.com/events.cfm
Toll-free: (877) 303-7908
International: (678) 373-0875

Replay Number (Toll Free): (855) 859-2056
Replay Number (International): (404) 537-3406
Conference ID #: 34406989

A webcast replay will be available on the Pharmacyclics website for 30 days.

About Pharmacyclics

Pharmacyclics® is a biopharmaceutical company focused on developing and
commercializing innovative small-molecule drugs for the treatment of cancer
and immune mediated diseases. Our mission and goal is to build a viable
biopharmaceutical company that designs, develops and commercializes novel
therapies intended to improve quality of life, increase duration of life and
resolve serious unmet medical healthcare needs; and to identify and control
promising product candidates based on scientific development and
administrational expertise, develop our products in a rapid, cost-efficient
manner and pursue commercialization and/or development partners when and where
appropriate.

Pharmacyclics markets IMBRUVICA and has three product candidates in clinical
development and several preclinical molecules in lead optimization. The
company is committed to high standards of ethics, scientific rigor, and
operational efficiency as it moves each of these programs to viable
commercialization.

Pharmacyclics is headquartered in Sunnyvale, California and is listed on
NASDAQ under the symbol PCYC. To learn more about how Pharmacyclics advances
science to improve human healthcare visit us at www.pharmacyclics.com.



SOURCE Pharmacyclics, Inc.

Website: http://www.pharmacyclics.com
 
Press spacebar to pause and continue. Press esc to stop.